Immuuntherapie van kanker
Author:
Osanto S.,Kruit W. H. J.
Publisher
Bohn Stafleu van Loghum
Reference12 articles.
1. Bruggen P van der, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T-lymphocytes on a human melanoma. Science 1991;254:1643–7.
2. Dudley ME. Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002;298:850–4.
3. Heslop HE, Brenner MK, Rooney CM. Donor T cells to treat EBV-associated lymphoma. N Engl J Med 1994;331:679–80.
4. Hodi FS, Mohm MC, Soiffer RJ et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Scie USA 2003;100:4712–7.
5. Hsu FJ, Clemens BC, Czerwinski D, et al. Tumor-specific idiotype in the treatment of patients with B-cell lymphoma long-term results of a clinical trial. Blood 1997;89:3129–35.